Get the app
US › Healthcare

Surrozen Inc (SRZN)

US · Healthcare · Biotechnology

$16.94+0.06%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$5.0M
Revenue YoY
+408.6%
Net profit
$50.2M
Profit YoY
+26.2%
EPS
$-0.41
EPS estimate
$-1.34
Net margin
1,003.5%

EPS came in at -0.41 against a street estimate of -1.34 — a beat of 69.4%.

Key statistics

Market cap
$228.6M
Forward P/E
0.0
P/B
2.50
Book value
$-18.60
EPS (TTM)
$-38.96
52-week high
$35.00
52-week low
$11.25
50-day MA
$22.71
200-day MA
$24.15
Beta
0.56

Analyst view

Analysts rate Surrozen Inc a strong buy (2 buy, 0 hold, 0 sell out of 2) with an average price target of $44.80.

Shareholding

Insiders
3.14%
Institutions
104.85%

Largest institutional holders

FundStake
TCG Crossover Management, LLC12.53%
Kalehua Capital Management LLC6.55%
Boxer Capital Management, LLC6.52%
StemPoint Capital LP6.14%
Millennium Management LLC5.81%
VR Adviser, LLC5.38%
Spruce Street Capital LP3.68%
BRAIDWELL LP3.37%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Surrozen Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.